22UA Dividend History & Analysis | N/A Yield

22UA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

Yield 12m -
Payout Ratio -
Growth Rate CAGR 5y -100.00%
Consistency Lifetime 1.0%
Yield on Cost 5y -
Payout FCF -
Streak Years -
Dividend Rating 1.00%

Dividends Cash Amount per Share Yearly

This chart shows the yearly cash amount paid as dividends per share. The exact values for each year can be found in the structured dataset with the html-id #yearly_dividend_dataset below.
Dividend Growth Year over Year This chart shows the annual dividend growth rate compared to the previous year.
5 Years Chart with Price and Dividend Yield This chart shows the dividend yield and price over time. Price is displayed as gray area (left axis), yield as dark blue line (right axis), and average yield as orange dashed line.
■ Yield (right) | ■ Price (left) | ┅ Avg Yield
Total Return 12m: -18.2%
Total Return 5y: -3.9%

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 387,093 M 3.34% 7.76%
AMGN 198,244 M 3.21% 6.0%
GILD 176,133 M 2.79% 5.72%
HLN 46,623 M 1.76% 2.46%
BIM 13,657 M 0.74% 0.75%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,397 M 134% 95.6%
HLN 46,623 M 30.1% 100%
AMGN 198,244 M 7.84% 100%
BIM 13,657 M 9.76% 96.0%
ABBV 387,093 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
 3.21% Yield
GILD
Gilead Sciences
 2.79% Yield

22UA Dividend History: Last 1 Payments (EUR) as of February 2026

Ex-Dividend Date Record Date Payment Date Period Dividend per Share Dividend Growth Rate QoQ Payout Yield
2022-06-02 1.8036 0% 1.19%

22UA Dividend FAQ

BioNTech SE (XETRA: 22UA) is a German biotech firm that leverages its mRNA platform to develop a broad pipeline of cancer immunotherapies. Its current clinical portfolio spans early-stage (Phase 1) to late-stage (Phase 3) trials, including BNT111 for advanced melanoma, BNT311/GEN1046 (acasunlimab) in Phase 3 for solid tumors, and BNT327 targeting multiple indications such as small-cell lung cancer and hepatocellular carcinoma. The company, founded in 2008 and headquartered in Mainz, focuses on both solid-tumor and hematologic indications across a range of trial phases.

What is the Dividend Yield of 22UA?

As of February 2026, 22UA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - EUR by the current share price of 92.55.

Does 22UA pay a dividend?

As of February 2026 22UA does not pay a dividend.

How often does 22UA pay dividends?

Over the last 12 months, 22UA has issued 0 dividend payments. The last dividend payment was made on 2022-06-02.

22UA dividend forecast

Based on historical data, the forecasted dividends per share for 22UA for the next 4 payments are between 0 (-100.0%) and 0 (-100.0%).
This represents a significant dividend cut compared to the last payment.

Will 22UA pay dividends in 2026?

The latest dividend paid per share was 1.80363 EUR with an Ex-Dividend Date of 2022-06-02. The next Ex-Dividend date for BioNTech SE (22UA) is currently unknown.

What is the next Ex-Dividend Date for 22UA?

The next Ex-Dividend date for BioNTech SE (22UA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of 22UA?

22UA's average dividend growth rate over the past 5 years is -100% per year.
Negative growth: 22UA's Dividend growth is negative and declining.

What is the Yield on Cost of 22UA?

22UA's 5-Year Yield on Cost is -%. If you bought 22UA's shares at 96.28 EUR five years ago, your current annual dividend income (- EUR per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of 22UA?

22UA Payout Consistency is 1.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Very unstable: BioNTech SE has a poor track record of dividend payments over its lifetime.

Does 22UA have a good Dividend Yield?

22UA`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of 22UA?

The Dividend Payout Ratio of 22UA is unknown.

What is the Dividend Rating of 22UA?

22UA`s Overall Dividend Rating is 1.00%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

22UA Outstanding Shares Analysis

What is the Trend in 22UA's Outstanding Shares?

BioNTech SE's outstanding shares have increased by approximately 0.57% annually over the past 3 years (Trend Reliability: 100.0%).

Neutral: Share count is relatively stable with minor dilution. This has minimal impact on dividend per share calculations.

Has 22UA ever had a Stock Split?

No stock splits on record. The share count changes shown above reflect buybacks, new issuance, or employee compensation rather than structural splits.

Year Number of Shares Annual Growth Rate
2021 242,521,500
2022 243,215,200 +0.29%
2023 237,725,700 -2.26%
2024 239,970,800 +0.94%
2025 240,455,500 +0.2%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-02-04 02:41